Manufacturer record
Shine Pharmaceuticals Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Shine Pharmaceuticals Limited (Gujarat) were declared Not of Standard Quality between December 2020 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 05P23T03, Lorazepam Tablets IP 2 mg (Proline-2) (exp Feb 2027). State Lab Karnataka (state lab) found it not of standard quality: Assay for Lorazepam. Listed in the June 2025 alert.
Records by type
9 records linked to Shine Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Lorazepam Tablets IP 2 mg (Proline-2) | Batch 05P23T03Mfg Mar 2023 · Exp Feb 2027 | Assay for LorazepamAssay | State Lab KarnatakaState lab | Jun 2025 |
| Lorazepam Tablets IP 1 mg (PROLINE - 1) | Batch 06P23T03Mfg Aug 2023 · Exp Apr 2027 | AssayAssay | CDTL MumbaiCDSCO lab | Jan 2025 |
| Clonazepam TabletsI.P.0.5mg | Batch 04L23T0 3Mfg Dec 2023 · Exp Nov 2026 | The sample does not conforms to claim as per IP in respect to The Test of Related SubstancesRelated substances | CDL KolkataCDSCO lab | May 2024 |
| Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | Batch 43L22T01Mfg Mar 2022 · Exp Feb 2025 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2023 |
| Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | Batch 43L23T01Mfg Feb 2023 · Exp Jan 2026 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2023 |
| Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | Batch 43L22T03Mfg Sep 2022 · Exp Aug 2025 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2023 |
| Atorvastatin Calcium Tablets I.P. 40 mg | Batch 17T20T07Mfg Oct 2020 · Exp Sep 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2022 |
| TLM-80 (Telmisartan Tablets I.P. 80 mg) | Batch 31T20T02Mfg Aug 2020 · Exp Jul 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2021 |
| Alora 0.25 (Alprazolam Tablets I.P. 0.25 mg) | Batch 03A19T02Mfg Nov 2019 · Exp Oct 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.